"Miraculins Inc. (MOM) - Product Pipeline Analysis, 2014 Update" Is Now Available at Fast Market Research

Boston, MA -- (SBWIRE) -- 11/05/2014 -- Miraculins Inc. (Miraculins) is a medical device company. The company develops and commercializes diagnostic tests for the healthcare market. It provides discovery and validation of cancer biomarkers for development of diagnostic tools and therapeutic products. Miraculins products include PREVU skin cholesterol test and Scout DS non-invasive diabetes screening test. The company's testing services utilizes PSP94 RUO kit. It utilizes the B.E.S.T platform technology for screening and identification of target proteins and peptides related to diseases. The company partners with Inverness Medical Innovations, Inc., a developer of consumer medical diagnostic products, for the development and commercialization of Miraculins preeclampsia technology. Miraculins is headquartered in Winnipeg, Manitoba, Canada.